Journal
/
/
MR Imaging Molecolare del cancro alla prostata con un piccolo Molecular CLT1 Peptide mirato di contrasto agente
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
DOI:

06:54 min

September 03, 2013

, , , ,

Chapters

  • 00:05Title
  • 02:09Confirmation of Tumor Binding Specificity of CTL1-dL-(Gd-DOTA)4 Peptides with Fluorescence Imaging and Histology
  • 03:13Magnetic Resonance Imaging
  • 05:01Representative Results
  • 06:06Conclusion

Summary

Automatic Translation

Per dimostrare imaging molecolare del cancro RM con un piccolo peptide mirato MRI mezzo di contrasto specifico alle proteine ​​plasmatiche coagulato in stroma tumorale in un modello di cancro alla prostata del mouse.

Related Videos

Read Article